StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Regen BioPharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$445.25K. For fiscal 2025 it was -$383.59K. The highest annual figure on record is $18.65K in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$383.59K–
FY2024Sep 30, 2024-$751.54K–
FY2023Sep 30, 2023-$173.92K–
FY2022Sep 30, 2022-$606.92K–
FY2021Sep 30, 2021-$1.13M-6165.6%
FY2020Sep 30, 2020$18.65K–
FY2019Sep 30, 2019-$481.79K–
FY2018Sep 30, 2018-$1.58M–
FY2017Sep 30, 2017-$1.89M–
FY2016Sep 30, 2016-$1.67M–
FY2015Sep 30, 2015-$1.19M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$24.07K–
Q2 FY2026CQ1 2026Mar 31, 2026-$63.23K–
Q1 FY2026CQ4 2025Dec 31, 2025-$197.94K–
Q4 FY2025CQ3 2025Sep 30, 2025-$160.01K–
Q3 FY2025CQ2 2025Jun 30, 2025-$55.98K–
Q2 FY2025CQ1 2025Mar 31, 2025-$101.23K–
Q1 FY2025CQ4 2024Dec 31, 2024-$66.38K–
Q4 FY2024CQ3 2024Sep 30, 2024-$207.29K–
Q3 FY2024CQ2 2024Jun 30, 2024-$172.59K–
Q2 FY2024CQ1 2024Mar 31, 2024-$209.32K–
Q1 FY2024CQ4 2023Dec 31, 2023-$162.34K–
Q4 FY2023CQ3 2023Sep 30, 2023-$23.41K–
Q3 FY2023CQ2 2023Jun 30, 2023-$87.01K–
Q2 FY2023CQ1 2023Mar 31, 2023-$53.04K–
Q1 FY2023CQ4 2022Dec 31, 2022-$10.46K–
Q4 FY2022CQ3 2022Sep 30, 2022-$85.29K–
Q3 FY2022CQ2 2022Jun 30, 2022-$123.68K–
Q2 FY2022CQ1 2022Mar 31, 2022-$118.82K–
Q1 FY2022CQ4 2021Dec 31, 2021-$279.14K–
Q4 FY2021CQ3 2021Sep 30, 2021-$1.07M–
Q3 FY2021CQ2 2021Jun 30, 2021-$63.92K–
Q2 FY2021CQ1 2021Mar 31, 2021$0–
Q1 FY2021CQ4 2020Dec 31, 2020$0-100.0%
Q4 FY2020CQ3 2020Sep 30, 2020$0–
Q3 FY2020CQ2 2020Jun 30, 2020$0–
Q2 FY2020CQ1 2020Mar 31, 2020-$5.66K–
Q1 FY2020CQ4 2019Dec 31, 2019$24.30K–
Q4 FY2019CQ3 2019Sep 30, 2019-$136.96K–
Q3 FY2019CQ2 2019Jun 30, 2019-$67.29K–
Q2 FY2019CQ1 2019Mar 31, 2019-$127.51K–
Q1 FY2019CQ4 2018Dec 31, 2018-$150.03K–
Q4 FY2018CQ3 2018Sep 30, 2018-$465.64K–
Q3 FY2018CQ2 2018Jun 30, 2018-$81.43K–
Q2 FY2018CQ1 2018Mar 31, 2018-$403.51K–
Q1 FY2018CQ4 2017Dec 31, 2017-$627.27K–
Q4 FY2017CQ3 2017Sep 30, 2017-$623.02K–
Q3 FY2017CQ2 2017Jun 30, 2017-$417.21K–
Q2 FY2017CQ1 2017Mar 31, 2017-$349.90K–
Q1 FY2017CQ4 2016Dec 31, 2016-$504.30K–
Q4 FY2016CQ3 2016Sep 30, 2016-$398.50K–

More Regen BioPharma figures

See a number that looks wrong?